More free syringes, fewer drug injectors in the case of Spain

被引:21
作者
Bravo, Maria J. [1 ]
Royuela, Luis
Barrio, Gregorio
de la Fuente, Luis
Suarez, Monica
Brugal, M. Teresa
机构
[1] Univ Complutense, Dept Prevent Med, Salud Publ & Hist Ciencia, E-28040 Madrid, Spain
[2] European Monitoring Ctr Drugs & Drug Addict, Lisbon, Portugal
[3] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain
[4] Sectretaria Plan Nacl Sobre Siba, Madrid, Spain
[5] Agencia Salud Publ Barcelona, Barcelona, Spain
关键词
needle exchange programs; drug injection; route of drug administration; Spain; HIV;
D O I
10.1016/j.socscimed.2007.05.004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
International policy on the prevention of HIV and other health problems among drug users should be guided by scientific evidence. However, it has frequently been argued that Needle Exchange Programs (NEPs) have negative effects such as facilitation of injection of illicit drugs, without providing evidence to support this hypothesis. Since the early 1980s Spain has experienced a severe HIV epidemic among drug injectors. A delayed but comprehensive implementation of harm reduction programs has taken place since the early 1990s. This paper assesses trends between 1991 and 2004, both in the number of sterile syringes exchanged or delivered by NEPs or other programs to improve injectors' access to sterile injection material, and in the number of injectors admitted to first treatment for heroin or cocaine dependence, as a proxy for trends in the number of new drug injectors in Spain. The results show increased access to sterile syringes and a sharp decrease in the number of new drug injectors, suggesting that NEPs have not promoted drug injection. A positive overall transition from injecting to smoking was also observed in the most frequent route of heroin or cocaine administration. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1773 / 1778
页数:6
相关论文
共 21 条
[1]   Global overview of injecting drug use and HIV infection among injecting drug users [J].
Aceijas, C ;
Stimson, GV ;
Hickman, M ;
Rhodes, T .
AIDS, 2004, 18 (17) :2295-2303
[2]   Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic [J].
Bravo, MJ ;
Barrio, G ;
de la Fuente, L ;
Royuela, L ;
Domingo, L ;
Silva, T .
ADDICTION, 2003, 98 (06) :749-760
[3]  
BRUGAL MT, 2003, PUB SEISIDA, V14, P152
[4]  
BRUGAL MT, 2006, GACETO SANITARIA, V20, P130
[5]  
Castelnuovo P, 2000, Acta Otorhinolaryngol Ital, V20, P6
[6]  
De la Fuente L, 1997, ADDICTION, V92, P1749, DOI 10.1111/j.1360-0443.1997.tb02895.x
[7]   Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors [J].
De la Fuente, L ;
Bravo, MJ ;
Barrio, G ;
Parras, F ;
Suárez, M ;
Rodés, A ;
Noguer, I .
CLINICAL INFECTIOUS DISEASES, 2003, 37 :S410-S415
[8]   More than thirty years of illicit drugs in Spain: a bitter story with some messages for the future [J].
de la Fuente, Luis ;
Teresa Brugal, M. ;
Domingo-Salvany, Antonia ;
Bravo, Maria J. ;
Neira-Leon, Montserrat ;
Barrio, Gregorio .
REVISTA ESPANOLA DE SALUD PUBLICA, 2006, 80 (05) :505-520
[9]   Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes [J].
de la Fuente, Luis ;
Bravo, Maria Jose ;
Toro, Carlos ;
Brugal, M. Teresa ;
Barrio, Gregorio ;
Soriano, Vicente ;
Vallejo, Fernando ;
Ballesta, Rosario .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2006, 60 (06) :537-542
[10]  
*DGPNSD, 1997, SIST EST INF SOBR TO